Preventing Hypertension in Pre-Hypertensive Patients
Author Information
Author(s): Fuchs Flávio D, Fuchs Sandra C, Moreira Leila B, Gus Miguel, Nóbrega Antônio C, Poli-de-Figueiredo Carlos E, Mion Décio, Bortoloto Luiz, Consolim-Colombo Fernanda, Nobre Fernando, Coelho Eduardo Barbosa, Vilela-Martin José F, Moreno Heitor Jr, Cesarino Evandro José, Franco Roberto, Brandão Andréa Araujo, de Sousa Marcos R, Ribeiro Antônio Luiz Pinho, Jardim Paulo Cesar, Neto Abrahão Afiune, Scala Luiz César N, Mota Marco, Chaves Hilton, Alves João Guilherme, Filho Dario C Sobral, Pereira e Silva Ricardo, Neto José A Figueiredo, Irigoyen Maria Cláudia, Castro Iran, Steffens André Avelino, Schlatter Rosane, de Mello Renato Bandeira, Mosele Francisca, Ghizzoni Flávia, Berwanger Otávio
Primary Institution: Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Hypothesis
Does an association of low doses of chlorthalidone and amiloride reduce the incidence of hypertension in individuals with pre-hypertension?
Conclusion
The early use of blood pressure-lowering drugs may prevent cardiovascular events and the incidence of hypertension in individuals with pre-hypertension.
Supporting Evidence
- Blood pressure-lowering drugs can reduce the incidence of hypertension.
- Non-drug interventions have shown low long-term effectiveness.
- Diuretics may be particularly efficacious in preventing hypertension.
Takeaway
This study is trying to find out if a combination of two medicines can help people who are at risk of getting high blood pressure, so they can stay healthy.
Methodology
Randomized, double-blind, placebo-controlled clinical trial with participants aged 30 to 70 years with pre-hypertension.
Potential Biases
Potential biases may arise from the involvement of pharmaceutical companies in funding and conducting trials.
Limitations
The study may have limitations related to the generalizability of the findings to populations outside Brazil.
Participant Demographics
Participants aged 30 to 70 years with pre-hypertension.
Statistical Information
P-Value
0.05
Confidence Interval
95% CI: 0.25-0.44
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website